Xencor | XNCR - 보통주 자본

주가
12.40
매일 변경
-0.41 -3.20%
매월
4.47%
매년
48.15%
Q2 예상
12.42




보통주 자본 변화 날짜
AbbVie USD 1.77B 1.75B 2025-06
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
Amgen USD 539M 1000K 2025-12
Arrowhead Research USD 135.7M 2.44M 2025-09
AstraZeneca USD 1.55B 206K 2025-12
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Cytokinetics USD 122.26M 145K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
J&J USD 2.41B 584K 2025-09
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
MacroGenics USD 63.32M 60K 2025-12
Merck USD 2.49B 15.79M 2025-09
Novartis USD 1.91B 10.64M 2025-12
Pfizer USD 5.69B 1000K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Xencor USD 71.87M 529K 2025-12